Skip to content

A STUDY HELD TO SEE THE EFFECT OF NIMBADI BIDALAKA IN THE MANAGEMENT OF KRIMIGRANTHI (BLEPHARITIS)

A SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFICACY OF NIMBADI BIDALAKA IN THE MANAGEMENT OF KRIMIGRANTHI (BLEPHARITIS)

Status
Recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/03/050424
Enrollment
31
Registered
2023-03-07
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H010- Blepharitis

Interventions

None listed

Sponsors

Kirti Kailasrao Sengaonkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 The Patients presenting sign and symptoms of Krimigranthi with Itching of eyelids Burning sensation Lacrimation and white scales along the base of eyelashes 2 Between the age group 18 to 60 years

Exclusion criteria

Exclusion criteria: 1 Blepharitis associated with conjunctivitis and Ulcerative Blepharitis 2 Patients suffering from Ptosis Psoriasis Drug induced Blepharitis

Design outcomes

Primary

MeasureTime frame
Nimbadi Bidalaka is effective in the management of Krimigranthi (Blepharitis).Timepoint: 5 days with 2 follow up (0th day and 6th day)

Secondary

MeasureTime frame
There is significant effect of Nimbadi Bidalaka on Krimigranthi (Blepharitis )Timepoint: 5 days with 2 follow ups (0th day and 6th day)

Countries

India

Contacts

Public ContactDr Santosh Rahinj

Dr D Y Patil College of Ayurved and Research Centre Pimpri Pune

santoshrahinj@yahoo.in8600866097

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026